145 related articles for article (PubMed ID: 11214744)
1. Accelerated dobutamine stress testing: safety and feasibility in patients with known or suspected coronary artery disease.
Lu D; Greenberg MD; Little R; Malik Q; Fernicola DJ; Weissman NJ
Clin Cardiol; 2001 Feb; 24(2):141-5. PubMed ID: 11214744
[TBL] [Abstract][Full Text] [Related]
2. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
Elhendy A; van Domburg RT; Poldermans D; Bax JJ; Nierop PR; Geleijnse ML; Roelandt JR
Diabetes Care; 1998 Nov; 21(11):1797-802. PubMed ID: 9802723
[TBL] [Abstract][Full Text] [Related]
3. [Feasibility and safety of dobutamine stress echocardiography: experiences with 1,000 studies].
Zahn R; Lotter R; Nohl H; Schiele R; Bergmeier C; Zander M; Seidl K; Senges J
Z Kardiol; 1996 Jan; 85(1):28-34. PubMed ID: 8717145
[TBL] [Abstract][Full Text] [Related]
4. [The side effects and safety of the echo-dobutamine test. The experience with 373 patients].
Fetiveau R; Lanzarini L; Poli A; Diotallevi P; Mussini MF; Montemartini C; Previtali M
G Ital Cardiol; 1995 Feb; 25(2):193-201. PubMed ID: 7642024
[TBL] [Abstract][Full Text] [Related]
5. Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography.
Minardi G; Manzara C; Pulignano G; Pino PG; Pavaci H; Sordi M
Cardiovasc Ultrasound; 2007 Nov; 5():40. PubMed ID: 18031577
[TBL] [Abstract][Full Text] [Related]
6. [A comparison of echocardiography with dobutamine administration and the stress test in detecting coronary disease].
San Román JA; Vilacosta I; Castillo JA; Rollán MJ; Sánchez-Harguindey L
Rev Esp Cardiol; 1994 Apr; 47(4):221-6. PubMed ID: 8209088
[TBL] [Abstract][Full Text] [Related]
7. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.
Mertes H; Sawada SG; Ryan T; Segar DS; Kovacs R; Foltz J; Feigenbaum H
Circulation; 1993 Jul; 88(1):15-9. PubMed ID: 8319327
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonging peak dobutamine dose during stress echocardiography.
Weissman NJ; Rose GA; Foster GP; Picard MH
J Am Coll Cardiol; 1997 Mar; 29(3):526-30. PubMed ID: 9060888
[TBL] [Abstract][Full Text] [Related]
9. Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography.
Dodi C; Pingitore A; Sicari R; Bruno G; Cordovil A; Picano E
Eur Heart J; 1997 Feb; 18(2):242-7. PubMed ID: 9043840
[TBL] [Abstract][Full Text] [Related]
10. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly.
Elhendy A; van Domburg RT; Bax JJ; Valkema R; Reijs AE; Krenning EP; Roelandt JR
Chest; 2000 Mar; 117(3):649-56. PubMed ID: 10712987
[TBL] [Abstract][Full Text] [Related]
11. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.
Poldermans D; Fioretti PM; Boersma E; Forster T; van Urk H; Cornel JH; Arnese M; Roelandt RT
Am J Cardiol; 1994 Mar; 73(7):456-9. PubMed ID: 8141086
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the echo-dobutamine-atropine test and ergometric test in the diagnosis of coronary disease].
Sarullo FM; Schicchi R; Schirò M; Schillaci AM; Ascione A; Bonnì G; Americo L; Orlando G; Andolina S; Adamo M; Castello A
G Ital Cardiol; 1996 Nov; 26(11):1279-90. PubMed ID: 9036024
[TBL] [Abstract][Full Text] [Related]
13. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing.
Hays JT; Mahmarian JJ; Cochran AJ; Verani MS
J Am Coll Cardiol; 1993 Jun; 21(7):1583-90. PubMed ID: 8496523
[TBL] [Abstract][Full Text] [Related]
14. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment.
San Román JA; Vilacosta I; Castillo JA; Rollán MJ; Peral V; Sánchez-Harguindey L; Fernández-Avilés F
Chest; 1996 Nov; 110(5):1248-54. PubMed ID: 8915229
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease.
Previtali M; Lanzarini L; Fetiveau R; Poli A; Ferrario M; Falcone C; Mussini A
Am J Cardiol; 1993 Oct; 72(12):865-70. PubMed ID: 8213540
[TBL] [Abstract][Full Text] [Related]
16. [Symptoms, complications and hemodynamic changes related to dobutamine stress echocardiography].
Pinton R; Lemke W; Garcia LG
Arq Bras Cardiol; 1997 Sep; 69(3):161-4. PubMed ID: 9595726
[TBL] [Abstract][Full Text] [Related]
17. Tolerance, hemodynamic changes, and safety of dobutamine stress perfusion imaging.
Dakik HA; Vempathy H; Verani MS
J Nucl Cardiol; 1996; 3(5):410-4. PubMed ID: 8902673
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease.
Burger AJ; Notarianni MP; Aronson D
Am J Cardiol; 2000 Oct; 86(8):825-9. PubMed ID: 11024395
[TBL] [Abstract][Full Text] [Related]
19. On-line quantitative assessment of left ventricular filling during dobutamine stress echocardiography: a useful addition to conventional wall motion scoring.
Vitarelli A; Luzzi MF; Penco M; Fedele F; Dagianti A
Int J Cardiol; 1997 Mar; 59(1):57-69. PubMed ID: 9080026
[TBL] [Abstract][Full Text] [Related]
20. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years.
Secknus MA; Marwick TH
J Am Coll Cardiol; 1997 May; 29(6):1234-40. PubMed ID: 9137218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
